Published Online
on February 13, 2003

A more recent version of this article appeared on March 1, 2003

This Article Full Text (PDF) All Versions of this Article: 34/3/718    most recent 01.STR.0000056171.55342.FFv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yoneda, Y. Articles by Mori, E. Search for Related Content PubMed PubMed Citation Articles by Yoneda, Y. Articles by Mori, E. Related Collections Health policy and outcome research Acute Cerebral Infarction Emergency treatment of Stroke

Submitted on August 5, 2002
Accepted on September 18, 2002

Hospital-Based Study of the Care and Cost of Acute Ischemic Stroke in Japan

Yukihiro Yoneda MD^*; Toshiyuki Uehara MD; Hiroshi Yamasaki MD; Yasushi Kita MD; Masayasu Tabuchi MD; and Etsuro Mori MD

From Neurology Service (Y.Y., T.U., H.Y., Y.K., M.T.) and Institute for Aging, Brain and Cognitive Disorders (E.M.), Hyogo Brain and Heart Center, Himeji, Japan.

^* To whom correspondence should be addressed. E-mail: yyoneda{at}hbhc.jp.

Background and Purpose--To evaluate the current status of care and cost of acute ischemic stroke in Japan, we performed a hospital-based analysis at a tertiary emergency hospital with a 24-hour neurology-neurosurgery team and care unit.

Methods--During the 12-month period of October 2000 to September 2001, we collected data on 179 patients consecutively hospitalized with acute ischemic stroke within 7 days of onset. We examined demographic data, in-hospital care, length of hospital stay, outcome at discharge, and hospital costs. The medical cost data were collected from official hospital medical cost charts, which calculated direct medical costs for beds, staff, examinations, medications, and rehabilitation.

Results--The mean age was 70 years, and 69% were male. Hospital arrival was within 3 hours of onset in 30% of the patients. A history of stroke was present in 37%. The mean initial National Institutes of Health Stroke Scale score was 8.3 points (median, 6 points). Using the Trial of Org 10172 in Acute Stroke Treatment classification, 25% were lacunar, 27% were atherothrombotic, 33% were cardioembolic, and 15% were of unknown origin. All patients underwent neuroimaging studies during hospitalization; 96% and 92% underwent CT and MRI with MR angiography, respectively. Antithrombotic medications were given in 94%, none of whom received thrombolysis. A newly licensed neuroprotective agent, edaravone, was given in 16%. More than half of the patients (55%) were initially admitted to the neurological intensive care unit. Overall, 64% received in-hospital rehabilitation. Mean length of stay was 33 days. In-hospital mortality rate was 3%. On the modified Rankin Scale (mRS), 63% were independent (mRS, 0 to 2) and 34% were dependent (mRS, 3 to 5) at discharge. Two thirds of the patients (65%) went directly back home. The mean hospital cost per patient was $6887 ($209/d), of which 69% was attributable to the costs for beds and staff, 12% for medications, 7% for rehabilitation, 6% for imaging studies, 5% for laboratory examinations, and 1% for other costs.

Conclusions--Despite the single hospital-based analysis, this study provided current, precise data on short-term inpatient care and costs of acute ischemic stroke in Japan. Because stroke often carries a permanent dependence, long-term cost-effective stroke care should be established.

Key words: costs and cost analysis • economics • Japan • stroke

This article has been cited by other articles:

				G. Saposnik, A. Baibergenova, M. O'Donnell, M. D. Hill, M. K. Kapral, V. Hachinski, and On behalf of the Stroke Outcome Research Canada (S Hospital volume and stroke outcome: Does it matter? Neurology, September 11, 2007; 69(11): 1142 - 1151. [Abstract] [Full Text] [PDF]

				T. Kawasaki, K. Ishihara, Y. Ago, A. Baba, and T. Matsuda Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one), a Radical Scavenger, Prevents 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Neurotoxicity in the Substantia Nigra but Not the Striatum J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 274 - 281. [Abstract] [Full Text] [PDF]

				Y. Kotani, K. Ishino, S. Osaki, O. Honjo, T. Suezawa, K. Kanki, C. Yutani, and S. Sano Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1626 - 1632. [Abstract] [Full Text] [PDF]

				H.-w. Yung, S. Korolchuk, A. M. Tolkovsky, D. S. Charnock-Jones, and G. J. Burton Endoplasmic reticulum stress exacerbates ischemia-reperfusion-induced apoptosis through attenuation of Akt protein synthesis in human choriocarcinoma cells FASEB J, March 1, 2007; 21(3): 872 - 884. [Abstract] [Full Text] [PDF]

				P. U. Heuschmann, P. L. Kolominsky-Rabas, B. Misselwitz, P. Hermanek, C. Leffmann, R. W. C. Janzen, J. Rother, H.-J. Buecker-Nott, K. Berger, and for The German Stroke Registers Study Group Predictors of In-Hospital Mortality and Attributable Risks of Death After Ischemic Stroke: The German Stroke Registers Study Group Arch Intern Med, September 13, 2004; 164(16): 1761 - 1768. [Abstract] [Full Text] [PDF]